PRKAA1 and neoplasm: Metformin can directly act on cancer cells by targeting the AMPK pathway in tumor cells that control metabolism, angiogenesis, inflammation and cancer stem cells [73], or by inhibiting cancer growth and proliferation via reducing insulinemia and glycemia [74].